HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dustin Elwood Selected Research

reluscovtogene ralaplasmid

1/2022Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates.
10/2021Intradermal-delivered DNA vaccine induces durable immunity mediating a reduction in viral load in a rhesus macaque SARS-CoV-2 challenge model.
1/2020Immunogenicity of a DNA vaccine candidate for COVID-19.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dustin Elwood Research Topics

Disease

3COVID-19
01/2022 - 01/2020
1Infections
01/2022
1Fever (Fevers)
01/2021
1Emerging Communicable Diseases (Emerging Infectious Diseases)
01/2021

Drug/Important Bio-Agent (IBA)

3reluscovtogene ralaplasmidIBA
01/2022 - 01/2020
2DNA VaccinesIBA
01/2022 - 01/2021
2VaccinesIBA
01/2022 - 01/2020
1Combined VaccinesIBA
01/2021
1AntigensIBA
01/2020
1AntibodiesIBA
01/2020
1A-Form DNA (A-DNA)IBA
01/2020